258 related articles for article (PubMed ID: 12917509)
1. Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing.
Thompson WG; Bergstralh EJ; Slezak JM
Obes Res; 2003 Aug; 11(8):1027-32. PubMed ID: 12917509
[TBL] [Abstract][Full Text] [Related]
2. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels in overweight and obese Asians.
Yang WS; Lee WJ; Funahashi T; Tanaka S; Matsuzawa Y; Chao CL; Chen CL; Tai TY; Chuang LM
Obes Res; 2002 Nov; 10(11):1104-10. PubMed ID: 12429873
[TBL] [Abstract][Full Text] [Related]
4. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
5. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
Love-Osborne K; Butler N; Gao D; Zeitler P
Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
7. Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.
Sesti G; Andreozzi F; Bonadonna RC; De Mattia G; Leonetti F; Luzi L; Marini MA; Natali A; Vettor R; Bonora E;
Diabetes Metab Res Rev; 2008 Feb; 24(2):130-6. PubMed ID: 17922529
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance is predicted by the high Fasting Insulin-to-Glucose ratio.
Guerrero-Romero F; Rodríguez-Morán M
Diabetes Metab; 2001 Apr; 27(2 Pt 1):117-21. PubMed ID: 11353876
[TBL] [Abstract][Full Text] [Related]
10. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
[TBL] [Abstract][Full Text] [Related]
11. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Chakarova N; Tankova T; Atanassova I; Dakovska L
Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
[TBL] [Abstract][Full Text] [Related]
13. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
14. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
Hadaegh F; Zabetian A; Harati H; Azizi F
Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
Andreozzi F; Succurro E; Mancuso MR; Perticone M; Sciacqua A; Perticone F; Sesti G
Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
18. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
[TBL] [Abstract][Full Text] [Related]
19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
20. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]